首页> 外文期刊>Vaccine >Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination
【24h】

Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination

机译:在大量感染HIV / HCV的患者中,对甲型和乙型肝炎病毒的免疫率以及与HAV和HBV疫苗接种相关的因素

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatitis A (HAV) and B (HBV) vaccination is strongly recommended for HIV-infected patients, especially those with hepatitis C coinfection. The aim of this study was to determine the prevalence of antibodies directed against HAV and HBV in a large cohort of HIV/HCV-coinfected patients, and to identify factors associated with HAV and HBV vaccination. Patients and methods: We studied 1175 HIV/HCV-coinfected patients enrolled in the ANRS CO13 HEPAVIH cohort, whose HAV and HBV serostatus was known. Resul
机译:强烈建议艾滋病毒感染的患者,尤其是丙型肝炎合并感染的患者接种甲型肝炎(HAV)和乙型肝炎(HBV)疫苗。这项研究的目的是确定针对大量感染HIV / HCV的患者中针对HAV和HBV的抗体的流行率,并确定与HAV和HBV疫苗接种相关的因素。患者和方法:我们研究了1175例被HIV / HCV感染的ANRS CO13 HEPAVIH队列患者,他们的HAV和HBV血清状况是已知的。结果

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号